The Missing Piece in Employee Cancer Benefits

When it comes to employee benefits programs, cancer detection and care are evolving. Right now, the majority of cancers go undetected for too long(1), and 3 out of 4 cancers do not have guideline recommended screening tests(2). This article discusses how employers need to pay attention, as annual cancer related healthcare costs continue to rise at alarming rates(3). Self-insured employers shoulder a large part of this growing financial burden, as employers consistently rank cancer-related costs among their top three health expenses(4). Learn more about solutions currently available to help tackle this challenge head-on, including new multi-cancer early detection tests.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Cancer Statistics, 2021.
2. Data on fileGA-2021-0065. Screening includes methods with USPSTF A or B rating. SEER*Stat Database: Incidence – SEER 18 Regs Research Data, Nov 2017 Sub. Includes persons aged 50+ diagnosed 2006-2015.
3. https://www.fightcancer.org/sites/default/files/National%20Documents/Costs-of-Cancer-2020-10222020.pdf
4. GRAIL, LLC interview with Ron Fontanetta on February 4, 2022, former Willis Towers Watson consultant, based on his review of employer claims data.

White Paper from